Inactive Instrument

Press Releases Theralase Technologies Inc. Toronto S.E.

Equities

TLT

CA88337V1004

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Theralase Technologies shares update on Phase II Bladder Cancer study	Feb. 08	AQ
Theralase makes positive progress on Phase II study on bladder cancer; targets breakthrough designation with FDA	Dec. 04	AQ
Theralase Technologies : Amended LIFE Offering Document	23-10-27	PU
Non Muscle Invasive Bladder Cancer Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)	23-10-09	AQ
Theralase Technologies shares positive interim results from Phase II Bladder Cancer study	23-06-13	AQ
Theralase® Releases FY2022 Audited Financial Statements	23-04-26	AQ
Theralase Technologies : FY22 Management Discussion & Analysis – December 2022	23-04-25	PU
Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium	23-02-23	AQ
Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company	23-02-21	AQ
Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the AUA Annual Meeting	23-02-02	AQ
Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium	23-01-25	AQ
Theralase ® Announces Warrant Extension	23-01-05	AQ
Theralase Releases Q322 Interim Financial Statements	22-11-29	AQ
Theralase® Grants Stock Options	22-11-21	AQ
Theralase ® Closes Private Placement Equity Financing	22-11-17	AQ
Theralase Technologies : ® Commences $CAN 2.5 M Follow-On Private Placement Equity Financing	22-10-02	PU
Theralase® Announces Warrant Extension	22-09-29	AQ
Theralase Technologies : ® Announces Warrant Extension	22-09-28	PU
Theralase® Closes $2.5M Private Placement Equity Financing	22-09-22	AQ
Theralase Technologies : ® Closes $2.5M Private Placement Equity Financing	22-09-21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Theralase Technologies Inc. Toronto S.E.

Equities

TLT

CA88337V1004

Press Releases

Filters